AMI ORGANICS | SOTAC PHARMACEUTICALS LTD. | AMI ORGANICS/ SOTAC PHARMACEUTICALS LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 102.0 | - | - | View Chart |
P/BV | x | 7.7 | 13.6 | 56.4% | View Chart |
Dividend Yield | % | 0.2 | 0.0 | - |
AMI ORGANICS SOTAC PHARMACEUTICALS LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMI ORGANICS Mar-23 |
SOTAC PHARMACEUTICALS LTD. Mar-23 |
AMI ORGANICS/ SOTAC PHARMACEUTICALS LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,182 | NA | - | |
Low | Rs | 826 | NA | - | |
Sales per share (Unadj.) | Rs | 169.2 | 96.3 | 175.8% | |
Earnings per share (Unadj.) | Rs | 22.9 | 2.8 | 804.9% | |
Cash flow per share (Unadj.) | Rs | 26.2 | 5.7 | 462.9% | |
Dividends per share (Unadj.) | Rs | 3.00 | 0 | - | |
Avg Dividend yield | % | 0.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 163.0 | 12.4 | 1,313.6% | |
Shares outstanding (eoy) | m | 36.44 | 8.05 | 452.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.9 | 0 | - | |
Avg P/E ratio | x | 43.9 | 0 | - | |
P/CF ratio (eoy) | x | 38.3 | 0 | - | |
Price / Book Value ratio | x | 6.2 | 0 | - | |
Dividend payout | % | 13.1 | 0 | - | |
Avg Mkt Cap | Rs m | 36,590 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 488 | 26 | 1,895.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,167 | 775 | 796.0% | |
Other income | Rs m | 43 | 4 | 1,234.3% | |
Total revenues | Rs m | 6,211 | 778 | 797.9% | |
Gross profit | Rs m | 1,226 | 79 | 1,552.8% | |
Depreciation | Rs m | 123 | 23 | 541.8% | |
Interest | Rs m | 24 | 20 | 118.1% | |
Profit before tax | Rs m | 1,122 | 39 | 2,856.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 289 | 16 | 1,760.0% | |
Profit after tax | Rs m | 833 | 23 | 3,643.5% | |
Gross profit margin | % | 19.9 | 10.2 | 195.1% | |
Effective tax rate | % | 25.7 | 41.8 | 61.6% | |
Net profit margin | % | 13.5 | 3.0 | 457.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,701 | 471 | 997.2% | |
Current liabilities | Rs m | 1,628 | 458 | 355.5% | |
Net working cap to sales | % | 49.8 | 1.7 | 2,908.5% | |
Current ratio | x | 2.9 | 1.0 | 280.5% | |
Inventory Days | Days | 5 | 3 | 188.2% | |
Debtors Days | Days | 1,363 | 704 | 193.6% | |
Net fixed assets | Rs m | 2,969 | 265 | 1,120.2% | |
Share capital | Rs m | 364 | 81 | 452.6% | |
"Free" reserves | Rs m | 5,575 | 19 | 28,753.1% | |
Net worth | Rs m | 5,940 | 100 | 5,946.1% | |
Long term debt | Rs m | 6 | 78 | 8.1% | |
Total assets | Rs m | 7,669 | 736 | 1,041.5% | |
Interest coverage | x | 47.5 | 2.9 | 1,625.4% | |
Debt to equity ratio | x | 0 | 0.8 | 0.1% | |
Sales to assets ratio | x | 0.8 | 1.1 | 76.4% | |
Return on assets | % | 11.2 | 5.9 | 190.1% | |
Return on equity | % | 14.0 | 22.9 | 61.3% | |
Return on capital | % | 19.3 | 33.6 | 57.3% | |
Exports to sales | % | 59.1 | 0 | - | |
Imports to sales | % | 30.3 | 0 | - | |
Exports (fob) | Rs m | 3,644 | NA | - | |
Imports (cif) | Rs m | 1,866 | NA | - | |
Fx inflow | Rs m | 3,644 | 0 | 1,584,217.4% | |
Fx outflow | Rs m | 1,866 | 0 | - | |
Net fx | Rs m | 1,777 | 0 | 772,721.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 655 | 81 | 804.7% | |
From Investments | Rs m | -330 | -117 | 283.1% | |
From Financial Activity | Rs m | -123 | 131 | -93.3% | |
Net Cashflow | Rs m | 202 | 96 | 210.7% |
Indian Promoters | % | 39.9 | 72.9 | 54.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 15.8 | 9.0 | 175.5% | |
FIIs | % | 9.0 | 9.0 | 99.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 60.1 | 27.2 | 221.3% | |
Shareholders | 95,784 | 245 | 39,095.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare AMI ORGANICS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | AMI ORGANICS | SOTAC PHARMACEUTICALS LTD. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.48% | 0.00% | 0.19% |
1-Month | 10.82% | -8.21% | 0.44% |
1-Year | 17.70% | 0.82% | 54.60% |
3-Year CAGR | 9.74% | 0.27% | 14.83% |
5-Year CAGR | 5.74% | 0.16% | 19.92% |
* Compound Annual Growth Rate
Here are more details on the AMI ORGANICS share price and the SOTAC PHARMACEUTICALS LTD. share price.
Moving on to shareholding structures...
The promoters of AMI ORGANICS hold a 39.9% stake in the company. In case of SOTAC PHARMACEUTICALS LTD. the stake stands at 72.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AMI ORGANICS and the shareholding pattern of SOTAC PHARMACEUTICALS LTD..
Finally, a word on dividends...
In the most recent financial year, AMI ORGANICS paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 13.1%.
SOTAC PHARMACEUTICALS LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of AMI ORGANICS, and the dividend history of SOTAC PHARMACEUTICALS LTD..
For a sector overview, read our pharmaceuticals sector report.
Asian stocks inched higher on Tuesday as investors awaited a slew of economic data, corporate earnings and the U.S. Federal Reserve's policy meeting.